We compared the activity estimated by a pedometer and an accelerometer in coronary artery disease patients included in a phase III cardiac rehabilitation programme. Nine patients were divided into two groups and wore the pedometer for four weeks, and then subsequently the accelerometer for four weeks, or vice versa. The recorded daily exercise level (total daily steps and calories burned) was measured for each patient and compared with oxygen uptake and ventilatory threshold measured by ergospirometry at the end of the study. There was a significant correlation between the calories measured by the accelerometer and the ventilatory threshold (i.e. the sub-maximal capacity), r ¼ 0.75 (P ¼ 0.05). There was a significant correlation between the measured steps on the accelerometer and the ventilatory threshold, r ¼ 0.72 (P ¼ 0.07). There were no significant correlations for the pedometer. A questionnaire concerning ease of use of the sensors indicated that the cardiac patients favoured the pedometer.
Introduction
Patients admitted to hospital after an ischaemic cardiac event are educated about a healthy lifestyle in a cardiac rehabilitation programme. However, the challenge is to construct a rehabilitation programme that will motivate patients to continue being physically active after the programme ends. 1 -3 Several studies indicate that daily physical activity declines significantly after completion of rehabilitation. 4 In one study, fewer than 30% of patients admitted to hospital for acute coronary artery disease still adhered to the recommended physical activity 18 months after rehabilitation ended. 4 However, the GOSPEL study demonstrated that a multifactorial intervention continuing for three years after myocardial infarct is effective in decreasing the risk of several important cardiovascular outcomes. Regular contacts with the patient thus seem to encourage the adoption of a healthier and more active lifestyle in the long run. The GOSPEL study recorded a 6% increase in activity for the intervention group compared to the usual care group. 5 The prohibitive investment in manpower needed to follow up actively the growing number of patients with ischaemic heart disease has led to studies using information and computer technology. Several studies indicate that telecare using pedometers can increase physical activity in overweight and obese people. 6 However, there is not much information about the necessary characteristics of activity monitoring devices to assist cardiac patients in their rehabilitation process. One paper addressing cardiac patients reported mainly qualitative results, such as the patient's self-assessment of their health condition. 7 The aim of the present pilot study was to assess two portable exercise monitors for use in long-term cardiac rehabilitation.
Methods
An unblinded, two treatment, two period cross-over pilot study was run in the Rehabilitation and Health Centre at the Jessa Hospital (Hasselt, Belgium). The patients were in the chronic cardiac maintenance phase ( phase III rehabilitation), the rehabilitation period starting 10 -12 weeks after hospital discharge. 4 They visited the rehabilitation centre two or three times a week to engage in aerobic exercise, supervised by professional staff, and were asked to perform 30 -60 min of aerobic exercise on the other days of the week. The following exclusion criteria were applied when selecting the patients: presence of important arrhythmias, presence of angina pectoris or dyspnoea during exercise, unstable patients at risk of heart failure while training. All participating subjects signed an informed consent, and the study was approved by the appropriate ethics committee. A pedometer (Omron 720IT) and an accelerometer (Polar FA20 activity watch) were selected for the pilot study as these two sensors can record measurement data for several weeks, have a long battery life, a low cost, an easy user interface and have been favourably reviewed. 8 -11 Both systems allow transfer of the data to a website, which is a prerequisite for telerehabilitation purposes. For this transfer the motion sensors were connected to the USB port of an Internet-connected PC. The data measured by the pedometer included the number of calories burned, distance walked, the total steps and the aerobic steps. Aerobic steps are defined as steps done during more than 10 min of continuous brisk walking (more than 60 steps per min). The data measured by the accelerometer included the calories burned and the time of exercise. Also the accelerometer differentiated between two levels of activity: low intensity exercise that is supposed to bring health benefits and high intensity exercise that increases fitness. For both sensor devices, the calories burned were calculated based on the number of steps made, the patient's stride length, weight and height using a proprietary algorithm.
Study
The cardiac patients were divided into two groups. In the first group, patients wore the pedometer for four weeks, and then subsequently they wore the accelerometer for four weeks. In the second group, patients wore the accelerometer for four weeks and then subsequently they wore the pedometer for four weeks. Both the accelerometer and the pedometer required calibration to the individual to take account of stride length. The patients completed the calibration phase at the rehabilitation centre prior to the study. At the start of the pilot study, patients received the instruction to put on the monitor all day long, including when exercising at the rehabilitation centre. They could only take off the monitoring device during the night, while sleeping. In the pilot phase, the transmission of the data from the accelerometer and the pedometer was done in the rehabilitation centre each week during the patient's visit. Allocation of the cardiac patients to the two intervention groups was random.
At the end of the study, all patients performed a maximum cardiopulmonary exercise test on a bicycle ergometer. 12, 13 During the exercise test an electronically braked bicycle (Ergo 1500, Ergofit, Pirmasens, Germany) was used. The cycling frequency was set at 70 cycles/min and the test was ended when the patient failed to maintain a pedal frequency of at least 60/min. 12, 13 In addition, exercise tests were prematurely ended if myocardial ischaemia and/or severe ventricular arrhythmias occurred. Both the starting and incremental cycling resistance was set between 10 and 40 W and increased every minute to volitional fatigue. 14 Pulmonary gas exchange analysis was performed with a cardiopulmonary ergospirometry device (Schiller CS200; Schiller AG, Switzerland). Before every test, a gas and volume calibration was executed. During the tests, environmental temperature was kept stable (19 -218C). Oxygen uptake (VO 2 ), expiratory volume (VE) and respiratory exchange ratio (RER) were collected breathby-breath and averaged every 10 s. Using a 12-lead ECG device, heart rate (HR) was monitored and averaged every 10 s. In addition, maximum cycling resistance (W peak ) and total test duration were reported. The ventilatory threshold was calculated by the V-slope method. 15 In this method, exercise VCO 2 was plotted against exercise VE, so the break point of the two slopes was determined. The sub-maximum capacity corresponded to this ventilatory threshold.
Outcome measures
The outcome measures were the recorded daily exercise level (total daily steps and burned calories) and their correlation with the ventilatory threshold as well as the VO 2 peak, and participant satisfaction with the two sensor devices.
Analysis
The analysis was conducted using filtered data. Some patients forgot to wear their sensor on some days. On days with zero step counts, the missing data were replaced by an average for the same patient (average number of total steps in a day, average number of calories burned in a day). For a total of 11 days out of 504 days, a zero step count was replaced by an average step count for the corresponding patient. The number of calories burned and steps walked by day for each patient collected by the two sensor devices was correlated with ventilatory threshold measurement data to assess if these sensor devices could serve as good reflectors of sub-maximum capacity. 16 The daily number of calories burned and steps walked was correlated with VO 2 peak values as determined by ergospirometry. This analysis was done to assess whether the recorded data from the two sensor devices might be potential reflectors of the patient's maximum capacity.
Satisfaction
At the end of the study, patients were asked about their experiences with the monitoring devices using a satisfaction questionnaire. The objective of the questionnaire was to learn more about the barriers for use of sensor devices and the potential benefits. The questionnaire was constructed by a multidisciplinary team at the Jessa Hospital. The answers from the questionnaire were analysed, using Fisher's exact test, to detect whether they differed significantly between the two sensor devices.
Results
Ten cardiac patients agreed to participate in the pilot study. After the first week, one patient left the study. No data from this patient were used in the analysis. The mean age of the nine patients was 63 years (SD 9), their mean weight was 77 kg (SD 11) with a mean height of 166 cm (SD 10) resulting in a mean BMI of 28.2 kg/m 2 (SD 5). There were four male and five female patients.
The recorded measurements from the two sensor devices are summarized in Table 1 . The calorie measurements for the pedometer were corrected with an energy coefficient (EC) of walking for people with different ages. 17 The real calories burned were calculated as the product of the EC and the calorie measurement from the pedometer. No data from the accelerometer were available for patient 2, so complete data are shown for only eight patients.
There was a significant correlation between the calories measured by the accelerometer and the ventilatory threshold, r ¼ 0.75 (P ¼ 0.05), see Figure 1 . There was no significant correlation for the pedometer (P ¼ 0.42), see Figure 2 .
There was a significant correlation between the measured steps on the accelerometer and the ventilatory threshold, r ¼ 0.72 (P ¼ 0.07). There was no significant correlation for the pedometer (P ¼ 0.82).
There was no significant correlation between the average daily calories burned/steps walked by patient and the VO 2 peak for either of the monitoring devices.
Satisfaction
The answers to the satisfaction questions are summarized in Table 2 . The pedometer appeared to be easier to read, when compared with the activity watch and it also appeared to be more user-friendly, although the difference was not significant (P ¼ 0.1).
Discussion
The pilot study evaluated two different movement sensors in terms of usability and relation with exercise capacity for patients in the chronic cardiac maintenance phase of a rehabilitation programme. Both sensors could send data to a care centre which would facilitate a telerehabilitation programme. The main finding was a significant correlation between the energy expenditure (calories burned) as measured by the accelerometer and the ventilatory threshold of the patient at the end of the pilot. This finding supports the hypothesis that the accelerometer measurements are good reflections of the physical condition and habitual activity of the patient.
None of the patients found the use of the activity monitoring device troublesome and only a minority (3 patients out of 9) found it inconvenient to wear the device. More than half of the patients preferred automatic data uploading by means of a USB connection rather than recording the data daily on a paper form. During the study, the uploading was done at the rehabilitation centre, but patients could have uploaded the recorded data from a computer at home thereby creating a form of communication suitable for a telerehabilitation programme.
The satisfaction analysis also showed that nearly half the patients engaged in additional exercise while wearing the sensor devices. This observation is promising, since it is difficult to encourage cardiac patients to increase their activity level. 18 Our findings also agree with another controlled study that monitored patients' adherence to physical exercises for six months after having completed a cardiac rehabilitation program by wearing a pedometer and participating in counselling sessions. 19 There were significant improvements in cardiorespiratory fitness (P ¼ 0.01) compared to a control group that did not wear a pedometer. An earlier qualitative study in Japan assessed the quality of life using questionnaires involving cardiac patients that had been requested to wear a pedometer to monitor their daily activity level. 7 The study concluded that the patients who wore a pedometer experienced a higher quality of life than the control group.
The present study had some limitations. The small sample size and the high variability in the recorded data made it difficult to identify significant differences. Also the short time frame means that we do not know whether the more active lifestyle of the patients in the study remains over a longer period. In conclusion, our study shows that the measurement of physical activity in phase III rehabilitation, and the transfer to a central computer can be done by using a pedometer or an activity watch. The acceptance rate by the patients was good. For use in telerehabilitation, the accelerometer would be preferred, because its output correlates with submaximum exercise capacity. Large studies with long-term follow up are needed to prove the potential value of telemonitoring of daily physical activity in the phase III rehabilitation after acute ischaemic events. 
